{
    "Trade/Device Name(s)": [
        "AlloMap Heart Molecular Expression Testing",
        "AlloMap Heart Testing"
    ],
    "Submitter Information": "CareDx, Inc.",
    "510(k) Number": "K221640",
    "Predicate Device Reference 510(k) Number(s)": [
        "K073482"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OJQ"
    ],
    "Summary Letter Date": "April 7, 2023",
    "Summary Letter Received Date": "April 10, 2023",
    "Submission Date": "September 6, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.1163"
    ],
    "Regulation Name(s)": [
        "Cardiac Allograft Gene Expression Profiling Test System"
    ],
    "Analyte Class(es)": [
        "transplant",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "11 informative genes for cardiac rejection",
        "9 normalization and quality control genes"
    ],
    "Specimen Type(s)": [
        "Peripheral blood mononuclear cells"
    ],
    "Specimen Container(s)": [
        "BD Vacutainer CPT Cell Preparation tube with sodium citrate anticoagulant"
    ],
    "Instrument(s)/Platform(s)": [
        "Roche LightCycler 480 II (LC480) thermal cycler",
        "Analyzer Software SAX v1.2",
        "liquid handling instruments"
    ],
    "Method(s)/Technology(ies)": [
        "qRT-PCR",
        "Gene expression analysis",
        "Reverse transcriptase protocol",
        "Genomic assay panel"
    ],
    "Methodologies": [
        "Gene expression profiling",
        "RT-PCR",
        "Molecular expression testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "System",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for CareDx AlloMap Heart gene expression profiling test using Roche LC480 and modified SAX software to monitor heart transplant rejection risk",
    "Indications for Use Summary": "Aids in identifying heart transplant recipients (15+ years, 2+ months post-transplant) with stable allograft function who have low probability of moderate/severe acute cellular rejection, used in conjunction with standard clinical assessment",
    "fda_folder": "Cardiovascular"
}